Delivery Order SPE2DB22D1106-SPE2DB24FECF9
Award Date 2/28/24
Potential Completion Date 2/29/24
Potential Value $6.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,151.11 firm fixed-price delivery order is for the provision of Provocholine Inhalation Solution, a medical product. The contract has an ultimate completion date of July 24, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award is a delivery order valued at $4,795.66 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the provision of Provocholine Inhal Soln Pack 18ML. The contract has a non-set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop Support Medical, which...
- This federal contract award is a delivery order for $1,100.26 from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for Provocholine Inhal Soln Pack 18ML, a medical product, and has a firm fixed price. The contract has a completion date of May 21, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $4,857.15 firm fixed price delivery order is for Provocholine inhalation solution, a specialized pharmaceutical product. The delivery order is part of a larger, single-award indefinite delivery contract (IDC) between DLA Troop Support Medical and AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 with a...
- This is a $2,823.28 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The delivery order is for Provocholine Inhalation Solution, a pharmaceutical product, with a completion date of January 12, 2024. The contract is a firm fixed price arrangement and does not have a set-aside designation. Amerisourcebergen Drug Corp, as the prime contractor, has received numerous previous awards from DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,902.34 firm fixed-price delivery order is for the supply of Provocholine Inhal Soln Pack 18ML, a medical product. The contract has an ultimate completion date of July 14, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency (DLA) awarded a $2,200.52 delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML pack quantities. This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of September 4, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under AmerisourceBergen's...
- This delivery order, valued at $2,423.36, awards AmerisourceBergen Drug Corp the supply of Provocholine inhalation solution in 18ML packs. The contract was competitively awarded without a set-aside designation on September 22, 2025, with an ultimate completion date of September 23, 2025. AmerisourceBergen will perform this work at its corporate office location in Conshohocken, Pennsylvania. The Defense Logistics Agency, which serves as the funding federal agency, utilizes this delivery order...
- This federal contract award, valued at $4,497.31, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Provocholine Inhalation Solution Packs, a medical product used in healthcare applications. The award is a Delivery Order contract with a Firm Fixed Price pricing type, and an ultimate completion date of February 6, 2025. This contract does not have a set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $7,459.23 to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs, with an ultimate completion date of November 4, 2025. This contract was competitively awarded without set-aside designation and utilizes firm fixed price pricing. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FECF9Delivery Order
This federal contract award is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $6,722.48 order is for the supply of Provocholine Inhalation Solution, a specialty pharmaceutical product, to support military medical treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA with a potential value of $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense. This contract does not have a set-aside designation.
Generated 5/29/24, 9:37 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 2/28/24 |